{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:51:28Z","timestamp":1780732288368,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jacadv.2025.101719","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:27:52Z","timestamp":1743553672000},"page":"101719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Post-Transcatheter Aortic Valve Replacement Antithrombotic Treatment in Nonindicated Patients"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6164-0886","authenticated-orcid":false,"given":"Sahand","family":"Siami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2559-0858","authenticated-orcid":false,"given":"Sina","family":"Kazemian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Jodeiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Ebrahimzade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Hajiqasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maede","family":"Mehdizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Aghaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Mahdi","family":"Bastan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrshad","family":"Fathian Sabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roozbeh","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3694-6863","authenticated-orcid":false,"given":"Pouya","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal S.","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Nanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhaval","family":"Kolte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor","family":"Biering-S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3847-0959","authenticated-orcid":false,"given":"Mohamad","family":"Alkhouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jacadv.2025.101719_bib1","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.3390\/jcm11082190","article-title":"Antithrombotic therapy following transcatheter aortic valve replacement","volume":"11","author":"Granger","year":"2022","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.jacadv.2025.101719_bib2","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jacc.2019.06.076","article-title":"Transcatheter versus surgical aortic valve replacement in low-risk patients","volume":"74","author":"Kolte","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2025.101719_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.20517\/2574-1225.2022.34","article-title":"Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement (TAVR): from current evidence to perspective","volume":"6","author":"Mauri","year":"2022","journal-title":"Mini-invasive Surg"},{"key":"10.1016\/j.jacadv.2025.101719_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.892956","article-title":"Periprocedural strategies for stroke prevention in patients undergoing transcatheter aortic valve implantation","volume":"9","author":"Linder","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"15","key":"10.1016\/j.jacadv.2025.101719_bib5","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jcin.2021.06.020","article-title":"Antithrombotic therapy after transcatheter aortic valve replacement","volume":"14","author":"Capodanno","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"13","key":"10.1016\/j.jacadv.2025.101719_bib6","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/eurheartj\/ehae043","article-title":"Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial","volume":"45","author":"Thyregod","year":"2024","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.jacadv.2025.101719_bib7","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.amjcard.2011.07.049","article-title":"Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation","volume":"108","author":"Ussia","year":"2011","journal-title":"Am J Cardiol"},{"issue":"13","key":"10.1016\/j.jacadv.2025.101719_bib8","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jcin.2017.04.014","volume":"10","author":"Rod\u00e9s-Cabau","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.jacadv.2025.101719_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019604","article-title":"Aspirin alone versus dual antiplatelet therapy after transcatheter aortic valve implantation: a systematic review and patient-level meta-analysis","volume":"10","author":"Brouwer","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"15","key":"10.1016\/j.jacadv.2025.101719_bib10","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJMoa2017815","article-title":"Aspirin with or without clopidogrel after transcatheter aortic-valve implantation","volume":"383","author":"Brouwer","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101719_bib11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijcard.2014.04.170","article-title":"SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation","volume":"174","author":"Stabile","year":"2014","journal-title":"Int J Cardiol"},{"issue":"24","key":"10.1016\/j.jacadv.2025.101719_bib12","doi-asserted-by":"crossref","first-page":"7632","DOI":"10.3390\/jcm12247632","article-title":"Antithrombotic management for transcatheter aortic valve implantation","volume":"12","author":"Ya'Qoub","year":"2023","journal-title":"J Clin Med"},{"issue":"13","key":"10.1016\/j.jacadv.2025.101719_bib13","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.3390\/jcm13133636","article-title":"Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation","volume":"13","author":"Pallante","year":"2024","journal-title":"J Clin Med"},{"issue":"21","key":"10.1016\/j.jacadv.2025.101719_bib14","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMoa1509233","article-title":"Possible subclinical leaflet thrombosis in bioprosthetic aortic valves","volume":"373","author":"Makkar","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101719_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.009983","article-title":"Randomized trial of aspirin versus warfarin after transcatheter aortic valve replacement in low-risk patients","volume":"14","author":"Rogers","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.jacadv.2025.101719_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ccd.30532","article-title":"Direct oral anticoagulant versus antiplatelet therapy following transcatheter aortic valve replacement in patients without prior or concurrent indication for anticoagulation: a meta-analysis of randomized studies","volume":"101","author":"Barbosa Moreira","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.jacadv.2025.101719_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-042587","article-title":"Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement","volume":"11","author":"Park","year":"2021","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.jacadv.2025.101719_bib18","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCULATIONAHA.122.059512","article-title":"Edoxaban versus dual antiplatelet therapy for leaflet thrombosis and cerebral thromboembolism after TAVR: the ADAPT-TAVR randomized clinical trial","volume":"146","author":"Park","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacadv.2025.101719_bib19","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1911425","article-title":"A controlled trial of rivaroxaban after transcatheter aortic-valve replacement","volume":"383","author":"Dangas","year":"2020","journal-title":"N Engl J Med"},{"issue":"29","key":"10.1016\/j.jacadv.2025.101719_bib20","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1093\/eurheartj\/ehac242","article-title":"Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial","volume":"43","author":"Collet","year":"2022","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.jacadv.2025.101719_bib21","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/eurheartj\/ehs255","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document","volume":"33","author":"Kappetein","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2025.101719_bib22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.amjcard.2023.08.076","article-title":"Aspirin versus warfarin after transcatheter aortic valve replacement in low-risk patients: 2-year follow-up","volume":"206","author":"Merdler","year":"2023","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.jacadv.2025.101719_bib23","doi-asserted-by":"crossref","first-page":"e1392","DOI":"10.4244\/EIJ-D-17-00198","article-title":"Which is the best antiaggregant or anticoagulant therapy after TAVI? A propensity-matched analysis from the ITER registry. The management of DAPT after TAVI","volume":"13","author":"D'Ascenzo","year":"2017","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101719_bib24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1253\/circj.CJ-16-0903","article-title":"Clinical outcomes and bioprosthetic valve function after transcatheter aortic valve implantation under dual antiplatelet therapy vs. Aspirin alone","volume":"81","author":"Ichibori","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.jacadv.2025.101719_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.amjcard.2023.04.014","article-title":"Medium-term outcomes of the different antithrombotic regimens after transcatheter aortic valve implantation","volume":"198","author":"Naser","year":"2023","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.jacadv.2025.101719_bib26","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"77","author":"Otto","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jacadv.2025.101719_bib27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.jacadv.2025.101719_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/ehjcvp\/pvad003","article-title":"Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trials","volume":"9","author":"Guedeney","year":"2023","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"5","key":"10.1016\/j.jacadv.2025.101719_bib29","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/ehjcvp\/pvad101","article-title":"Antithrombotic therapy in patients after transcatheter aortic valve implantation: a network meta-analysis","volume":"10","author":"Turgeon","year":"2023","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"5","key":"10.1016\/j.jacadv.2025.101719_bib30","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1097\/MS9.0000000000001908","article-title":"Efficacy and outcomes of antiplatelet therapy versus oral anticoagulants in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis","volume":"86","author":"Goyal","year":"2024","journal-title":"Ann Med Surg"},{"issue":"22","key":"10.1016\/j.jacadv.2025.101719_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm11226781","article-title":"The efficacy and safety of direct oral anticoagulants versus standard of care in patients without an indication of anti-coagulants after transcatheter aortic valve replacement: a meta-analysis of randomized controlled trials","volume":"11","author":"Abuelazm","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacadv.2025.101719_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20406223211056730","article-title":"Efficacy and safety of antithrombotic therapy with non-vitamin K antagonist oral anticoagulants after transcatheter aortic valve replacement: a systematic review and meta-analysis","volume":"12","author":"An","year":"2021","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.jacadv.2025.101719_bib33","article-title":"Non-vitamin K oral anticoagulant after transcatheter aortic valve replacement: a systematic review and meta-analysis","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"issue":"18","key":"10.1016\/j.jacadv.2025.101719_bib34","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.jcin.2023.07.005","article-title":"Incidence, predictors, and prognostic impact of bleeding events after TAVR according to VARC-3 criteria","volume":"16","author":"Avvedimento","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.jacadv.2025.101719_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019490","article-title":"Duration of antiplatelet therapy following transcatheter aortic valve replacement: systematic review and network meta-analysis","volume":"10","author":"Kuno","year":"2021","journal-title":"J Am Heart Assoc"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X2500136X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X2500136X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T21:09:24Z","timestamp":1748466564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X2500136X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2772963X2500136X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.101719","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-Transcatheter Aortic Valve Replacement Antithrombotic Treatment in Nonindicated Patients","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.101719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101719"}}